Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Multiple sclerosis (MS) is a T-cell mediated autoimmune disease of
the central nervous system (CNS). Much research related to the
immunological aspects of MS has focused on defining the nature of the
antigen(s) against which the immune response is generated and the
molecule(s) responsible for presentation of these antigens. For many
years, the dogma has been that T-cells recognize peptide antigens
presented in the context of M11C molecules and substantial research
has defined peptide antigens that may contribute to the pathogenesis
of MS. Recently, it hasbeen shown that molecules of the CD1 family
can act as restriction elements in lipid antigen presentations to
specialized subsets of T-cells suggesting that the spectrum of
antigens to which T-cells respond may be broader than previously
thought. Studies on the identification of these antigens have thus
far been directed only to bacterial components. CD1 glycoproteins are
cell surface molecules, noncovalently linked to beta2-microglobulin
and structurally related to major histocompatibility (M11C) antigens.
The CD I family includes CD I a, b and c proteins, products of
separate genes that all map to chromosome 1, having molecular masses
of 49, 45, and 43 kDa respectively. They are found on all cortical
thymocytes, but not on circulating T-cells or monocytes, and are
differentially expressed by subpopulations of dendritic cells,
Langerhans cells (CDI a and CD I c), subsets of B-cells (CD I c),
certain T-cell leukemias, and tissue macrophages in some inflammatory
lesions. In the brain, CD I a has been reported on microglia by some
investigators, but not others. Battistini et al.. have shown that
CDlb, is expressed in active MS lesions. Since lipids, particularly
glycolipids, are a major component of the myelin membrane it is
reasonable to consider that lipids may be involved in the
immunopathology of MS. The immune response would include CD1
molecules presenting lipid antigens to specialized populations of
T-cells. To test this hypothesis, the first step is to isolate and
characterize a purified lipid antigen that elicits a T-cell response.
Recent work has suggested that the glycolipids that elicit the most
response contain unusual fatty acids and long chain bases. Therefore,
it is important to find if unusual fatty acids or long chain bases are
expressed in MS tissues.
No Sub Projects information available for 5P41RR010888-05 0030
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR010888-05 0030
Patents
No Patents information available for 5P41RR010888-05 0030
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR010888-05 0030
Clinical Studies
No Clinical Studies information available for 5P41RR010888-05 0030
News and More
Related News Releases
No news release information available for 5P41RR010888-05 0030
History
No Historical information available for 5P41RR010888-05 0030
Similar Projects
No Similar Projects information available for 5P41RR010888-05 0030